Sakar Healthcare Limited share price
NSE: SAKAR · ISIN INE732S01012
Key numbers
- Market cap
- ₹ 2,493 Cr
- Current price
- ₹ 1,135.85
- 52-week high / low
- ₹ 1,230 / 346
- Stock P/E
- 82.5
- Book value
- ₹ 146.0
- Dividend yield
- 0.00%
- ROCE
- 12.4%
- ROE
- 10.0%
- Debt to equity
- 0.22
- Sales growth (3 yrs)
- 23.6%
- Profit growth (3 yrs)
- 33.7%
- 1-year return
- 208.8%
About Sakar Healthcare Limited
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company offers general and oncology products in various forms, such as liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. It also exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 50 | 53 | 58 | 70 | 71 |
| Operating profit | 16 | 13 | 11 | 19 | 26 |
| Net profit | 6 | 5 | 5 | 10 | 11 |
| EPS (₹) | 2.66 | 2.11 | 2.03 | 4.59 | 4.96 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.